REGN-1400

Product Description: REGN-1400 is a humanized monoclonal antibody inhibitor targeting ErbB3. REGN-1400 reduces tumor cell proliferation by inhibiting ErbB3 and blocking related signaling pathways. REGN-1400 is promising for research of solid tumors such as non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and squamous cell carcinoma of the head and neck (SCCHN) [1].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]Papadopoulos K P, et al. Phase 1 study of REGN1400 (anti-ErbB3) combined with erlotinib or cetuximab in patients (pts) with advanced non-small cell lung cancer (NSCLC), colorectal cancer (CRC), or head and neck cancer (SCCHN)[J]. 2014.

Molecular Weight: N/A

Research Area: Cancer

Target: EGFR

• Artikelnummer: MEXHY-P991244-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P991244-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK
• Konjugat: Unconjugated